Butt Muhammad I, Siddiqi Ahmad M, Joueidi Faisal M
College of Medicine, Alfaisal University, Riyadh, SAU.
Medicine, King Faisal Specialist Hospital and Research Centre, Riyadh, SAU.
Cureus. 2023 Apr 27;15(4):e38210. doi: 10.7759/cureus.38210. eCollection 2023 Apr.
The pituitary gland is a rare metastatic site, and thyroid cancer (TC) metastasis to the pituitary gland is immensely uncommon. We report the case of a 45-year-old male in whom pituitary metastasis (PM) discovery during the immediate postoperative period complicated the management of papillary thyroid cancer (PTC). His postoperative magnetic resonance imaging (MRI) of the pituitary lesion showed a progression in size with persistent optic nerve compression. The critical location of the pituitary lesion and the rapid progression dictated the treatment course. The pituitary lesion was non-iodine avid, and thus we opted for external beam radiation therapy (EBRT). He received 1,200 centigray (cGy) with Gamma knife radiosurgery with steroid cover. In our case, the aggressive histological and clinical variant of PTC consisted of multiple metastatic sites involving large volume pulmonary, skeletal, and chest wall lesions coupled with crucial macro metastatic pituitary mass. The patient was offered radioactive iodine to treat other iodine avid metastases in the lungs and bones and was also offered EBRT to target skeletal lesions. Systemic treatment with tyrosine kinase inhibitor was also discussed with the patient. Our case encourages clinicians to exercise vigilance and a high index of suspicion for PM when a patient with any pre-existing cancer presents with visual disturbance, cranial nerve deficit, or symptoms suggestive of hormonal deficiency. It also highlights the importance of involving endocrinologists before performing any surgery on the endocrine organs to ascertain the integrity of the endocrine function of the glands.
垂体是一个罕见的转移部位,甲状腺癌(TC)转移至垂体极为罕见。我们报告一例45岁男性患者,其在甲状腺乳头状癌(PTC)术后即刻发现垂体转移(PM),这使PTC的治疗变得复杂。他术后垂体病变的磁共振成像(MRI)显示病变大小进展,视神经持续受压。垂体病变的关键位置及快速进展决定了治疗方案。垂体病变对碘不摄取,因此我们选择了外照射放疗(EBRT)。他接受了1200厘戈瑞(cGy)的伽玛刀放射外科治疗,并给予类固醇保护。在我们的病例中,PTC侵袭性的组织学和临床特征包括多个转移部位,累及大量肺部、骨骼和胸壁病变,以及关键的垂体大转移瘤。为患者提供了放射性碘以治疗肺部和骨骼的其他碘摄取转移灶,同时也提供了EBRT以靶向骨骼病变。还与患者讨论了使用酪氨酸激酶抑制剂进行全身治疗。我们的病例提醒临床医生,当任何既往有癌症的患者出现视觉障碍、颅神经缺损或激素缺乏症状时,要对垂体转移保持警惕并高度怀疑。这也凸显了在对内分泌器官进行任何手术前,让内分泌科医生参与以确定腺体内分泌功能完整性的重要性。